Home Cart Sign in  
Chemical Structure| 301305-73-7 Chemical Structure| 301305-73-7

Structure of TCS 359
CAS No.: 301305-73-7

Chemical Structure| 301305-73-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TCS 359, a 2-acylaminothiophene-3-carboxamide, is a potent inhibitor of FLT3 with IC50 of 42 nM.

Synonyms: FLT3 Inhibitor; Fms-like Tyrosine Kinase Inhibitor; TCS359, TCS 359, TCS-359, Flt-3 inhibitor

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TCS 359

CAS No. :301305-73-7
Formula : C18H20N2O4S
M.W : 360.43
SMILES Code : O=C(C1=C(NC(C2=CC=C(OC)C(OC)=C2)=O)SC3=C1CCCC3)N
Synonyms :
FLT3 Inhibitor; Fms-like Tyrosine Kinase Inhibitor; TCS359, TCS 359, TCS-359, Flt-3 inhibitor
MDL No. :MFCD00617269
InChI Key :FSPQCTGGIANIJZ-UHFFFAOYSA-N
Pubchem ID :1048845

Safety of TCS 359

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of TCS 359

RTK

Isoform Comparison

Biological Activity

Description
TCS 359, a 2-acylaminothiophene-3-carboxamide, serves as a potent and selective FLT3 inhibitor with an IC50 of 42 nM. It also suppresses MV4-11 cell proliferation with an IC50 of 340 nM [1].

In Vitro:

Cell Line
Concentration Treated Time Description References
ImMKCLs 3.3 μM 10 days To evaluate the effect of TCS 359 on iPSC-derived MK maturation and PLP production. Results showed that TCS 359 significantly increased PLP yield. PMC6134216
3LL tumor cells 25, 50, 100 mg/ml 24, 48, 72 hours TCS inhibited the proliferation of 3LL cells in a time- and dose-dependent manner and induced apoptosis after 48 hours of treatment. PMC4002443
ImMKCLs 3.3 μM 7 days To evaluate the effect of TCS 359 on imMKCL maturation and platelet-like particle (PLP) production. Results showed that TCS 359 significantly increased PLP yield. PMC6134216

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6JRj mice Anti-GPIbα antibody-induced thrombocytopenia model Intraperitoneal injection 100 mg/kg From day 0 to day 6 To evaluate the effect of TCS 359 on platelet recovery. Results showed that TCS 359 significantly promoted platelet recovery. PMC6134216
C57BL/6 mice and nude mice Lewis lung cancer model Subcutaneous injection 0.4 mg/kg Once every other day for a total of five times TCS more significantly inhibited tumor growth and prolonged survival in immunocompetent mice than in nude mice, indicating that the host immune system was involved in tumor eradication. PMC4002443

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.87mL

2.77mL

1.39mL

27.74mL

5.55mL

2.77mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories